
Jean P. Cornet
Examiner (ID: 15666, Phone: (571)270-7669 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 1628 |
| Total Applications | 1519 |
| Issued Applications | 572 |
| Pending Applications | 146 |
| Abandoned Applications | 824 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18581556
[patent_doc_number] => 20230263808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => THERAPEUTIC USES OF GLUCOCORTICOIDS WITH ANABOLIC EFFECTS IN SKELETAL MUSCLE
[patent_app_type] => utility
[patent_app_number] => 18/007308
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007308 | THERAPEUTIC USES OF GLUCOCORTICOIDS WITH ANABOLIC EFFECTS IN SKELETAL MUSCLE | Oct 12, 2021 | Pending |
Array
(
[id] => 17836336
[patent_doc_number] => 20220273641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Method for treating coronavirus infections including SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/495827
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495827 | Method for treating coronavirus infections including SARS-CoV-2 | Oct 6, 2021 | Abandoned |
Array
(
[id] => 17533553
[patent_doc_number] => 20220112162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 17/495069
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495069 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Oct 5, 2021 | Pending |
Array
(
[id] => 19969608
[patent_doc_number] => 12338199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 17/494762
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 32
[patent_no_of_words] => 66897
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494762 | Bis-octahydrophenanthrene carboxamides and protein conjugates thereof | Oct 4, 2021 | Issued |
Array
(
[id] => 17828347
[patent_doc_number] => 20220265651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => PHARMACEUTICAL DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 17/489382
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489382
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489382 | PHARMACEUTICAL DOSAGE FORMS | Sep 28, 2021 | Abandoned |
Array
(
[id] => 18877428
[patent_doc_number] => 20240000797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => BIODEGRADABLE POLYMER DELIVERY SYSTEM FOR EXTENDED DELIVERY OF TESTOSTERONE
[patent_app_type] => utility
[patent_app_number] => 18/029443
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029443 | BIODEGRADABLE POLYMER DELIVERY SYSTEM FOR EXTENDED DELIVERY OF TESTOSTERONE | Sep 23, 2021 | Abandoned |
Array
(
[id] => 17503614
[patent_doc_number] => 20220096716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => MEDICAL IMPLANTS INCLUDING LAMINATES OF POLY-4-HYDROXYBUTYRATE AND COPOLYMERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/482063
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482063 | MEDICAL IMPLANTS INCLUDING LAMINATES OF POLY-4-HYDROXYBUTYRATE AND COPOLYMERS THEREOF | Sep 21, 2021 | Pending |
Array
(
[id] => 17458683
[patent_doc_number] => 20220071987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER
[patent_app_type] => utility
[patent_app_number] => 17/448488
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448488 | PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER | Sep 21, 2021 | Abandoned |
Array
(
[id] => 17620134
[patent_doc_number] => 11339170
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-24
[patent_title] => Spiropyrrolidine derived antiviral agents
[patent_app_type] => utility
[patent_app_number] => 17/479455
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15840
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479455 | Spiropyrrolidine derived antiviral agents | Sep 19, 2021 | Issued |
Array
(
[id] => 17334624
[patent_doc_number] => 20220000955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PHYTOESTROGEN PRODUCT OF RED CLOVER AND PHARMACEUTICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/479139
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479139
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479139 | PHYTOESTROGEN PRODUCT OF RED CLOVER AND PHARMACEUTICAL USES THEREOF | Sep 19, 2021 | Abandoned |
Array
(
[id] => 20562027
[patent_doc_number] => 12564617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Methods for modulating macrophage activity
[patent_app_type] => utility
[patent_app_number] => 17/478042
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 138
[patent_figures_cnt] => 127
[patent_no_of_words] => 49064
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478042 | Methods for modulating macrophage activity | Sep 16, 2021 | Issued |
| 17/477248 | Compounds and Methods for Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors | Sep 15, 2021 | Abandoned |
Array
(
[id] => 18752354
[patent_doc_number] => 20230355584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/245132
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245132
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/245132 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS | Sep 14, 2021 | Pending |
Array
(
[id] => 17702809
[patent_doc_number] => 20220202815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/472544
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472544 | TREATMENT OF CANCER | Sep 9, 2021 | Abandoned |
Array
(
[id] => 17702808
[patent_doc_number] => 20220202814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/472130
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472130 | TREATMENT OF CANCER | Sep 9, 2021 | Abandoned |
Array
(
[id] => 17687637
[patent_doc_number] => 20220194929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/470464
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470464 | Substituted anilines as CCR(4) antagonists | Sep 8, 2021 | Issued |
Array
(
[id] => 17312789
[patent_doc_number] => 20210401837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/469551
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469551
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469551 | TREATMENT OF CANCER | Sep 7, 2021 | Abandoned |
Array
(
[id] => 17334539
[patent_doc_number] => 20220000870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/469715
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17469715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/469715 | TREATMENT OF CANCER | Sep 7, 2021 | Abandoned |
Array
(
[id] => 18707517
[patent_doc_number] => 20230330093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => APPLICATION OF NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/024807
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024807
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024807 | APPLICATION OF NITROGEN-CONTAINING SATURATED HETEROCYCLIC COMPOUND | Sep 2, 2021 | Pending |
Array
(
[id] => 18245956
[patent_doc_number] => 11602519
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-03-14
[patent_title] => Method for preventing myocardial infarction using eucalyptol
[patent_app_type] => utility
[patent_app_number] => 17/465832
[patent_app_country] => US
[patent_app_date] => 2021-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 3608
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/465832 | Method for preventing myocardial infarction using eucalyptol | Sep 1, 2021 | Issued |